Skip to main content
. 2017 Jul 6;103(24):1992–1999. doi: 10.1136/heartjnl-2016-311022

Table 2.

Clinical outcomes of patients in the conservative management and initial AVR cohorts

Normal LVMI
N of patients with event/N of patients at risk (cumulative 5-year incidence (%))
High LVMI
N of patients with event/N of patients at risk (cumulative 5-year incidence (%))
Unadjusted Adjusted
HR
(95% CI)
p Value HR
(95% CI)
p Value p Value for interaction
A composite of aortic valve-related death or hospitalisation due to heart failure Conservative management cohort 164/691 (33) 582/1480 (49) 1.93
(1.63 to 2.31)
<0.001 1.53
(1.26 to 1.85)
<0.001 0.016
Initial AVR cohort 26/217 (14) 123/894 (16) 1.12
(0.75 to 1.75)
0.59 0.96
(0.60 to 1.55)
0.88
All-cause death Conservative management cohort 257/691 (42) 684/1480 (52) 1.36
(1.18 to 1.57)
<0.001 1.11
(0.94 to 1.30)
0.23 0.39
Initial AVR cohort 34/217 (19) 176/894 (23) 1.19
(0.84 to 1.75)
0.33 0.92
(0.61 to 1.39)
0.69
Aortic valve-related death Conservative management cohort 86/691 (17) 335/1480 (31) 1.98
(1.57 to 2.53)
<0.001 1.52
(1.18 to 1.96)
0.001 0.42
Initial AVR cohort 8/217 (5) 51/894 (6) 1.53
(0.77 to 3.48)
0.24 1.42
(0.65 to 3.08)
0.38
Heart failure hospitalisation Conservative management cohort 130/691 (28) 471/1480 (43) 1.98
(1.64 to 2.42)
<0.001 1.64
(1.33 to 2.02)
<0.001 0.0034
Initial AVR cohort 18/217 (10) 76/894 (12) 0.99
(0.61 to 1.71)
0.98 0.89
(0.50 to 1.57)
0.68

Other abbreviations are same as in table 1.

AVR, aortic valve replacement; LVMI, left ventricular mass index.